INVY HCG HP 5000IU Injection is an antineoplastic drug, classified as a luteinizing hormone analogue, and contains the active ingredient gonadotrophin. Its primary application is in fertility treatments, particularly to stimulate ovulation in women undergoing procedures such as in vitro fertilization (IVF). Beyond female fertility, this medicine is also utilized to stimulate testosterone production in males afflicted with hypogonadism, a condition characterized by insufficient natural testosterone synthesis. Additionally, it serves as a treatment for undescended testicles, facilitating their proper descent from a higher to a more typical anatomical position.
Patients receiving INVY HCG HP 5000IU Injection may experience common side effects, including localized reactions such as pain, redness, and swelling at the injection site, as well as systemic effects like headache, tiredness, depression, and fluid retention. Should any of these side effects be a concern or persist longer than expected, it is advisable to inform your healthcare provider. A notable and potentially serious risk associated with this medication is the increased likelihood of developing ovarian hyperstimulation syndrome (OHSS). Therefore, if you experience symptoms such as lower abdominal pain, rapid weight gain, or difficulty breathing, it is crucial to consult your doctor immediately, as OHSS can be a severe condition requiring urgent medical intervention.
INVY HCG HP 5000IU Injection is not recommended for pregnant women due to the potential for harm to the developing fetus. Healthcare professionals should exercise caution when administering this injection to individuals with a medical history of blood clots, heart disease, liver disease, or kidney disease. In the event of an allergic reaction to this injection, it is imperative to report it to your doctor immediately.
